Literature DB >> 22103020

Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and supplies. Final rule.

.   

Abstract

This final rule updates and makes certain revisions to the End-Stage Renal Disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2012. We are also finalizing the interim final rule with comment period published on April 6, 2011, regarding the transition budget-neutrality adjustment under the ESRD PPS,. This final rule also sets forth requirements for the ESRD quality incentive program (QIP) for payment years (PYs) 2013 and 2014. In addition, this final rule revises the ambulance fee schedule regulations to conform to statutory changes. This final rule also revises the definition of durable medical equipment (DME) by adding a 3-year minimum lifetime requirement (MLR) that must be met by an item or device in order to be considered durable for the purpose of classifying the item under the Medicare benefit category for DME. Finally, this final rule implements certain provisions of section 154 of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) related to the durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) Competitive Acquisition Program and responds to comments received on an interim final rule published January 16, 2009, that implemented these provisions of MIPPA effective April 18, 2009. (See the Table of Contents for a listing of the specific issues addressed in this final rule.)

Entities:  

Mesh:

Year:  2011        PMID: 22103020

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  16 in total

1.  Facility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Douglas S Fuller; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 8.237

2.  Weekly Standard Kt/Vurea and Clinical Outcomes in Home and In-Center Hemodialysis.

Authors:  Matthew B Rivara; Vanessa Ravel; Elani Streja; Yoshitsugu Obi; Melissa Soohoo; Alfred K Cheung; Jonathan Himmelfarb; Kamyar Kalantar-Zadeh; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 8.237

3.  Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis.

Authors:  Haesuk Park; Raj Desai; Xinyue Liu; Steven M Smith; Juan Hincapie-Castillo; Linda Henry; Amie Goodin; Saraswathi Gopal; Carl J Pepine; Raj Mohandas
Journal:  Clin J Am Soc Nephrol       Date:  2022-05-19       Impact factor: 10.614

4.  The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.

Authors:  Abhijit V Kshirsagar; Janet K Freburger; Alan R Ellis; Lily Wang; Wolfgang C Winkelmayer; M Alan Brookhart
Journal:  Am J Med       Date:  2013-04-15       Impact factor: 4.965

5.  Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Authors:  Marc N Turenne; Elizabeth L Cope; Shannon Porenta; Purna Mukhopadhyay; Douglas S Fuller; Jeffrey M Pearson; Claudia Dahlerus; Brett Lantz; Francesca Tentori; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2014-10-09       Impact factor: 10.121

6.  Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis survey.

Authors:  Robert Wood; Carly J Paoli; Ron D Hays; Gavin Taylor-Stokes; James Piercy; Matthew Gitlin
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 8.237

7.  International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.

Authors:  Douglas S Fuller; Brian A Bieber; Ronald L Pisoni; Yun Li; Hal Morgenstern; Tadao Akizawa; Stefan H Jacobson; Francesco Locatelli; Friedrich K Port; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

8.  Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013.

Authors:  Duc B Nguyen; Isaac See; Nicole Gualandi; Alicia Shugart; Christi Lines; Wendy Bamberg; Ghinwa Dumyati; Lee H Harrison; Lindsey Lesher; Joelle Nadle; Susan Petit; Susan M Ray; William Schaffner; John Townes; Levi Njord; Dawn Sievert; Nicola D Thompson; Priti R Patel
Journal:  Infect Control Hosp Epidemiol       Date:  2015-11-11       Impact factor: 3.254

9.  Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis.

Authors:  Matthew B Rivara; Todd Edwards; Donald Patrick; Lisa Anderson; Jonathan Himmelfarb; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-30       Impact factor: 8.237

10.  Reduced use of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: a managed care cost-offset model.

Authors:  Richard Mutell; Jaime L Rubin; T Christopher Bond; Tracy Mayne
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.